A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
In this conversation, Jacksonville Business Journal Editor-in-Chief James Cannon invites Ponte-Vedra based Cadrenal Founder & CEO Quang Pham to talk about the biopharmaceutical industry and financing.